FilingReader Intelligence
Yantai Dongcheng launches new radiopharmaceutical production center
July 15, 2025 at 09:52 AM UTC•By FilingReader AI
Yantai Dongcheng Biochemicals announced its subsidiary received approval for a radiopharmaceutical production center in Jiangxi Yichun.
The facility has commenced production of Fluorine-18 Fluorodeoxyglucose Injection and is expected to boost sales revenue and strengthen the company's nationwide radiopharmaceutical network.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
SZSE:002675•Shenzhen Stock Exchange
News Alerts
Get instant email alerts when Yantai Dongcheng Biochemicals publishes news
Free account required • Unsubscribe anytime